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Simultaneous fluorometry and phosphorometry of Langendorff perfused
rat heart: ex vivo animal studies
Abstract
Fluorescence imaging of intrinsic fluorophores of tissue is a powerful method to assess metabolic changes at
the cellular and intracellular levels. At the same time, exogenous phosphorescent probes can be used to
accurately measure intravascular tissue oxygenation. Heart failure is the leading cause of death in America. A
rat heart can potentially model the human heart to study failures or other abnormalities optically. We report
simultaneous fluorescence and phosphorescence measurements performed on a rat heart. We have used two
different optical systems to acquire fluorescence signals of flavoprotein and nicotinamide adenine
dinucleotide—the two intrinsic fluorophores of mitochondria—and the phosphorescence signal of an
intravascular oxygen probe to extract intracellular and intravascular metabolism loads, respectively.
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Fluorescence imaging of intrinsic fluorophores of tissue is a powerful method
to assess metabolic changes at the cellular and intracellular levels. At the same
time, exogenous phosphorescent probes can be used to accurately measure in-
travascular tissue oxygenation. Heart failure is the leading cause of death in
America. A rat heart can potentially model the human heart to study fail-
ures or other abnormalities optically. This paper reports simultaneous fluores-
cence and phosphorescence measurements performed on a rat heart. We have
used two different optical systems to acquire fluorescence signals of Fp (Flavo-
protein) and NADH (Nicotinamide Adenine Dinucleotide) - the two intrinsic
fluorophores of mitochondria - and the phosphorescence signal of an intravas-
cular oxygen probe to extract intracellular and intravascular metabolism loads
respectively.
c© 2006 Optical Society of America
OCIS codes: 300.6280, 170.6510, 170.3880, 170.3890
Optical imaging of tissue is a noninvasive and well-studied technique that has been widely
used in biomedical applications. Optical methods can be employed as a diagnostic or ther-
apeutic tool for ex vivo small animal studies and possibly for human disease diagnosis and
therapy. Heart failure is one of the leading high-risk diseases that can be optically investi-
gated. In this regard, the correlation of intracellular and vascular oxygen concentration in
a rat heart could be an important factor in vascular disease diagnosis and progression. In
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addition, it would be helpful to observe the oxygenation signals of the metabolic states of
tissue in open-heart surgeries. The Langendorff perfusion method has been used by many
research groups for myocardial ischemic border zones,1 regional ischemia in hypertrophia,2
and heart muscle oxygenation3 studies. In previous studies the NADH images of the ischemic
myocardium have clearly shown the LAD (left anterior descending artery) infarct borders3,4
and have been verified by microchemistry.5 Here we add a flavoprotein signal to obtain a
ratio metric redox. In this study, cardiac mitochondrial intrinsic fluorescence signals, Fp and
NADH, and phosphorescence of an exogenous oxygen probe (Oxyphor G3)6 are investigated.
While fluorometery has been used in this study to collect signals related to the tissue oxy-
genation state, a phosphorescent probe, dissolved in blood plasma, served as an indicator of
oxygen levels in the microvasculature.
Our fluorometer is a mobile optical-electrical apparatus that collects fluorescence signals
through a 3mm tip light guide. The light source is a brightline mercury arc lamp whose light
is filtered at 4 different wavelengths by passing through an air turbine rotating filter wheel
at a speed of 60 Hz. Consequently, up to four signals can be multiplexed to a photodetector
in order to make four-wavelength channel optical measurements of tissue metabolism.7 The
light intensity that is incident on tissue at the fiber tip is ∼ 3µw. This instrument has the
advantages of high speed time-sharing, mobility, simplicity, and high-resolution. Figure 1
shows the schematic of the fluorometer in acquiring spectroscopic heart data. For cardiac
fluorometery experiments, two channels are used for FP and NADH excitation: 420 nm
and 365 nm, respectively (interference filters: 440DF20, 365HT25). The emitted fluorescent
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signals at 520nm and 440nm for FP and NADH, respectively, are detected through a PMT
(photomultiplier tube) after passing through bandpass filters (interference filters: 525DF50,
455DF70). The signal is then digitized and displayed. Hence, the NADH and FP signals are
monitored online using surface fluorescence in an isolated working rat heart under different
heart rates.
Measuring intravascular oxygenation by phosphorescence quenching is a well known tech-
nique, widely used to study biological systems.8 Oxygen quenches the luminescence of exoge-
nous phosphorescent probes dissolved in the blood. The concentration of oxygen is inversely
proportional to phosphorescence lifetime (T) in accordance with the Stern-Volmer relation-
ship
T/T0 = 1 +Kq ∗ T0 ∗ [O2]
where Kq and T0 are probe related constants. In this study we used a new phosphores-
cent probe, Oxyphor G3 - Pd-tetrabenzoporphyrin-dendrimer, peripherally modified with
oligoethyleneglycole residues. Oxyphor G3 is confined to the microcirculation and does not
diffuse out into the interstitial space. The excitation wavelength for Oxyphor G3 is 635 nm
and its phosphorescence maximum is at 810 nm. Kq of 170 mmHg
−1s−1 and T0 = 270msec
make Oxyphor G3 well suited for oxygen measurements throughout the range of physiological
oxygen concentrations. Due to the position of the excitation band far in the red region (635
nm), a relatively deep tissue volume can be sampled using surface excitation of Oxyphor G3.
Consequently, in our experiments phosphorescent signals from Oxyphor G3 were so strong
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that the optical fiber (see below) could be positioned at a distance from the heart, and no
contact was required. Phosphorescence measurements were performed using a digital phos-
phorometer.9 In brief, the excitation source is a 3W LED (λmax = 635nm) and the detector
is an APD (3 µsec rise time). The excitation and the emission are conducted to and from the
instrument by a 3 mm bifurcated light guide. The emission is filtered through a long-pass
(695 nm cut-off) filter and focused on the APD by a spherical lens. The sample is excited
by a pulse of light (time-domain operation), and the phosphorescence decay is digitized and
analyzed to give the phosphorescence lifetime and oxygen concentration.
Vascular oxygen concentration measured by phosphorometry is closely related to the cel-
lular oxygenation state inferred from fluorometry. Figure 2 shows the two probes for fluores-
cence and phosphorescence simultaneous measurements. To minimize environmental light,
the room was dark and a black cloth surrounded the system after the probes were positioned.
Oxyphor G3 was added to the buffer which was continuously passing through the heart.
Although fluorescence spectroscopy of myocardium tissue is well-studied10,1, 11 and O2
probe monitoring is a known technique, simultaneous measurements of fluorescence and
phosphorescence have only been correlated to a limited extent. This experiment serves as
a control to correlate intracellular O2 concentration, which is deducted from mitochondrial
redox states, and vascular O2 concentration, which results from O2 probe monitoring. This
can be useful in studies of defective oxygen delivery, apoptosis, open chest surgery tissue
oxygenation monitoring, cancerous tissue studies, and oxygen endoscopy. In this regard, the
correlation of intracellular and vascular oxygen concentration in a rat heart could be an
5
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important study in vascular disease diagnosis and progression.
The apparatus for crystalloid perfusion is Langendorff System from ADInstruments using
Krebs Buffer (KHB) as perfusate. The gas used for crystalloid experiment is 95% oxygen,
5% carbon dioxide. Sprague-Dawley rats of approximately 300 grams are anesthetized with
a mixture of ketamine and acepromazine (1.0 mg/kg and 0.1 mg/kg, respectively). After
anesthesia, the hearts are rapidly excised and placed in ice-cold perfusate. Once perfused with
a buffered, oxygenated solution the heart will beat spontaneously, but during this experiment
it is paced using an external stimulator with a stimulus that exceeds the natural cardiac
pacemaker rate for different metabolic activities. Figure 3 displays the fluorescence and
the phosphorescence signals of myocardium, which are measured simultaneously in different
heart situations. As can be seen, the protocol starts at a heart rate of 200bpm with oxygen
bubbling in the buffer and continues with a systematic hypoxia for less than five minutes by
stopping the oxygen flow. Hence, the fluorescent signal of NADH increases with the stop of
oxygen flow due to the reduction of this fluorophore that is fluorescent in reduced form. On
the other hand, FP decreases at this interval because it also gets reduced while it is more
fluorescent in oxidized form. After this, the heart rate is increased by a stimulator to 300bpm
and 400bpm, and the same procedure of first section is executed. In the exact range of these
time events, which are emphasized with two vertical dashed lines, the phosphorescence signal
shows behavior that is consistent with the experimental protocol of flow and stop-flow of O2.
This suggests that intracellular and vascular tissue oxygen levels in each time slot are highly
correlated, though the trend of each fluorophore is quite different. The trend of the NADH
6
OSA
Published by
graph has a negative slope while for FP it has a positive slope which reflects a highly oxidized
myocardium due to global ischemia and probably initiation of apoptosis. On the other hand
there is a distinguishable difference in the exponential rate of NADH increase versus the
abrupt decrease of phosphorescence. This can suggest different sensitivities of these methods
to oxygen sensing.
In conclusion, any abnormality in oxygen delivery, cardiac respiratory chain, and hypertro-
phied hearts could suggest a decorrelation of fluorescence-phosphorescence traces . Therefore,
the 2D fluorescence or phosphorescence mapping provided by previous researchers2,4, 3 and
ourselves validates the hypothesis that direct fluorometry of mitochondrial signals and phos-
phorometry of vascular oxygen concentration are superior methods. These methods might
be not only the indicator of hypoxia but also an indicator of irreversible damage to the my-
ocardium in terms of activating apoptosis which causes a high redox ratio.12 Finally, these
noninvasive optical techniques can be advantageous in assessing tissue oxygenation on site
in open-heart surgery.
The author would like to thank A. Mu and Dr. K. Margulies for the rat heart facilities,
and C. Alter for experimental set up help. This work was supported in part by grant NIH
CA096016. Mahsa Ranji’s email is: mahsa@seas.upenn.edu.
References
1. A.H. Harken, C.H. Barlow, W.R. Harden, B.Chance, American J. of Cardiology 42,
(1978)
7
OSA
Published by
2. J.F. Ashruf, C. Ince, and H.A. Bruining, Am J Physiol Heart Circ Physiol 277, (1999).
3. C.H. Barlow, E. Bailey, K.A. Kelly, JJ. Kelly, Plentum Press, 1998.
4. O.G. Bjornsson, K. Kobayashi, and J.R. Williamson, Am. Physiol Soc, (1987).
5. B. Chance, B. Schoener, K. Krejci, H. Russmann, W. Wesemann, H. Schnitger, Th. and
Bucher, Biochem. Zeit, 341(1965).
6. I. B. Rietveld, E. Kim and S. A. Vinogradov, Tetrahedron, 59, (2003).
7. B. Chance, D. Mayer, N. Graham, V. and Legallais, Rev. Sci. Instru., 41, (1970).
8. D.F. Wilson, S.A. Vinogradov, Handbook of Biomedical Fluorescence, Marcel Dekker,
2003.
9. S. A. Vinogradov, M. A. Fernandez-Seara, B. W. Dugan and D. F. Wilson, Rev. Sci.
Instrum., 72, (2001).
10. F.W. Heineman and R.S. Balaban, Annu. Rev. Physiol. 42, (1990).
11. F.W. Heineman, R.S. Balaban, Am. J. Physiol. 264, (1993)
12. M. Ranji, D.L. Jaggard, B. Chance, Proc. of SPIE 6087, (2006).
8
OSA
Published by
Figure captions:
1) Two-wavelength time-shared fluorometer in rat heart fluorescence measurements and
digital time-domain phosphorometer to monitor intravascular pO2
2) Simultaneous fluorescence-phosphorescence measurements on a rat heart (upper center)
3) NADH, FP Fluorescence and O2 probe phosphorescence time events
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Fig. 1 Two-wavelength time-shared fluorometer in rat heart fluorescence measure-
ments and digital time-domain phosphorometer to monitor intravascular pO2
Fig. 2 Simultaneous fluorescence-phosphorescence measurements on a rat heart (upper
center)
Fig. 3 NADH, FP Fluorescence and O2 probe phosphorescence time events
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Fig. 1. Two-wavelength time-shared fluorometer in rat heart fluorescence measurements and
digital time-domain phosphorometer to monitor intravascular pO2
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Fig. 2. Simultaneous fluorescence-phosphorescence measurements on a rat heart (upper cen-
ter)
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Fig. 3. NADH, FP Fluorescence and O2 probe phosphorescence time events
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